BACKGROUND: Interferon-gamma assays (IGRAs) are alternatives to the tuberculin skin test (TST), but IGRA conversions and reversions are not well understood. In a pilot study, we determined conversions and reversions using QuantiFERON-TB Gold In-Tube((R)) (QFT) among household contacts of TB cases, and evaluated the effect of using various definitions and criteria for conversions. DESIGN: In a cohort of 250 contacts in India, 46% were TST-positive at baseline and 54% were QFT-positive. We re-tested this cohort after 12 months. Conversion rates were estimated using several definitions. RESULTS: Of the 250 contacts, 205 (82%) underwent repeat testing. Among 85 contacts with baseline TST-negative/QFT-negative results, TST conversion rates ranged between 7.5% and 13.8%, and QFT conversion rates ranged between 11.8% and 21.2%, depending on the definitions used. Among 109 contacts who were QFT-positive at baseline, seven (6.4%) had QFT reversions. QFT reversions were most likely when the baseline TST was negative and QFT results were just above the diagnostic cut-off. CONCLUSIONS: QFT conversions and reversions occurred among contacts of TB cases. Conversion rates seemed to vary, depending on the test and definitions used for conversions. These findings need to be verified in larger studies in various settings.
BACKGROUND:Interferon-gamma assays (IGRAs) are alternatives to the tuberculin skin test (TST), but IGRA conversions and reversions are not well understood. In a pilot study, we determined conversions and reversions using QuantiFERON-TB Gold In-Tube((R)) (QFT) among household contacts of TB cases, and evaluated the effect of using various definitions and criteria for conversions. DESIGN: In a cohort of 250 contacts in India, 46% were TST-positive at baseline and 54% were QFT-positive. We re-tested this cohort after 12 months. Conversion rates were estimated using several definitions. RESULTS: Of the 250 contacts, 205 (82%) underwent repeat testing. Among 85 contacts with baseline TST-negative/QFT-negative results, TST conversion rates ranged between 7.5% and 13.8%, and QFT conversion rates ranged between 11.8% and 21.2%, depending on the definitions used. Among 109 contacts who were QFT-positive at baseline, seven (6.4%) had QFT reversions. QFT reversions were most likely when the baseline TST was negative and QFT results were just above the diagnostic cut-off. CONCLUSIONS: QFT conversions and reversions occurred among contacts of TB cases. Conversion rates seemed to vary, depending on the test and definitions used for conversions. These findings need to be verified in larger studies in various settings.
Authors: Inger Brock; Karin Weldingh; Troels Lillebaek; Frank Follmann; Peter Andersen Journal: Am J Respir Crit Care Med Date: 2004-04-15 Impact factor: 21.405
Authors: E M S Leyten; C Prins; A W J Bossink; S Thijsen; T H M Ottenhoff; J T van Dissel; S M Arend Journal: Eur Respir J Date: 2007-01-10 Impact factor: 16.671
Authors: Luca Richeldi; Katie Ewer; Monica Losi; Barbara M Bergamini; Pietro Roversi; Jonathan Deeks; Leonardo M Fabbri; Ajit Lalvani Journal: Am J Respir Crit Care Med Date: 2004-05-06 Impact factor: 21.405
Authors: Philip C Hill; Roger H Brookes; Annette Fox; Katherine Fielding; David J Jeffries; Dolly Jackson-Sillah; Moses D Lugos; Patrick K Owiafe; Simon A Donkor; Abdulrahman S Hammond; Jacob K Otu; Tumani Corrah; Richard A Adegbola; Keith P W J McAdam Journal: Clin Infect Dis Date: 2004-03-16 Impact factor: 9.079
Authors: Sylvia M LaCourse; Lisa M Cranmer; Daniel Matemo; John Kinuthia; Barbra A Richardson; David J Horne; Grace John-Stewart Journal: J Acquir Immune Defic Syndr Date: 2017-05-01 Impact factor: 3.731
Authors: Felix C Ringshausen; Albert Nienhaus; José Torres Costa; Heiko Knoop; Stephan Schlösser; Gerhard Schultze-Werninghaus; Gernot Rohde Journal: Clin Vaccine Immunol Date: 2011-05-18
Authors: Christian Lienhardt; Katherine Fielding; Abdoul A Hane; Aliou Niang; Cheikh T Ndao; Farba Karam; Helen Fletcher; Fatou Mbow; Jules-François Gomis; Raymond Diadhiou; Roger Diadhiou; Maxime Toupane; Tandakha Dieye; Souleymane Mboup Journal: PLoS One Date: 2010-05-06 Impact factor: 3.240
Authors: Anja Schablon; Melanie Harling; Roland Diel; Felix C Ringshausen; Jose Torres Costa; Albert Nienhaus Journal: GMS Krankenhhyg Interdiszip Date: 2010-09-21
Authors: Felix C Ringshausen; Albert Nienhaus; Anja Schablon; Stephan Schlösser; Gerhard Schultze-Werninghaus; Gernot Rohde Journal: BMC Infect Dis Date: 2010-07-23 Impact factor: 3.090